32 results
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
15 Nov 21
Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development
8:00am
CEO and CFO. “We are aggressively pursuing the advancement of these potent compounds as we navigate a challenging global supply chain. Thankfully our … in the forward-looking statements include, but are not limited to, the risks arising from supply chain disruptions on our ability to obtain products including
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
10 Apr 23
Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30am
economies, including manufacturing and research delays arising from raw materials and labor shortages, supply chain disruptions and other business
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
24 Apr 23
Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors
8:13am
, and on the U.S., U.K., Australia and global economies, including manufacturing and research delays arising from raw materials and labor shortages, supply chain disruptions
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
26 Oct 22
Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344
8:00am
, including supply chain disruptions and our continued ability to proceed with our programs such as obtaining the requisite regulatory approvals including from
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
22 Dec 21
Regulation FD Disclosure
8:30am
statements include, but are not limited to, the risks arising from supply chain disruptions on our ability to obtain products including raw materials
8-K
EX-99.1
yacn 3hs792
11 May 22
Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
8:30am
8-K
EX-99.1
twxno5p 4t0wwoupse8
28 Mar 24
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
8:00am
8-K
EX-99.1
o5usz
23 Mar 22
Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones
4:05pm
8-K
EX-99.1
8gr7y
13 Nov 23
Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:15am
8-K
EX-99.1
9qi3u3
15 May 23
Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:00am
8-K
EX-99.1
v6r3jtmilode50b8
15 Aug 22
Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
8:00am
8-K
EX-99.1
fm3r quzscmniszs33
16 Aug 23
Cocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
4:05pm